Literature DB >> 26995116

Modified total meso-pancreatoduodenum excision with pancreaticoduodenectomy as a mesopancreatic plane surgery in borderline resectable pancreatic cancer.

Y Kawabata1, T Tanaka2, N Ishikawa3, H Hayashi2, Y Tajima2.   

Abstract

BACKGROUND: A superior mesenteric artery (SMA)-first approach has been considered to be an efficient technique in pancreaticoduodenectomy when the SMA is a factor of borderline resectable pancreatic head cancer (BRPHC). However, this excellent procedure has limitations in terms of tumor resection with an intact coverage including the pancreatic tumor and the tumor-draining lymphovascular systems and the ability to achieve a complete regional lymphadenectomy.
METHODS: A modified mesenteric plane procedure has been developed that provides improved regional lymphadenectomy and permits adjustment of the surgical approach, which is based on the direction of the tumor infiltration.
RESULTS: Of 55 patients taken to surgery, 19 had peritoneal dissemination and/or liver metastasis at staging laparoscopy, and the procedure revealed tumor infiltration to the SMA and/or hepatic artery (HA) in 4 patients. Finally, 32 patients with BRPHC have undergone the procedure between April 2009 and June 2015. Twenty-four of 32 patients (75.0%) had negative resection margins, and the median number of lymph nodes harvested was 34. Lymph nodes around the SMA tested positive for metastasis in 13 patients (40.6%), and those around the HA tested positive for metastasis in 7 patients (21.9%). Complications occurred in 14 patients (43.7%), with no perioperative mortality. Overall survival rates were 65.3% at 1 year and 35.2% at 3 years.
CONCLUSIONS: Short-term results with the procedure may encourage surgical management for BRPHC.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Artery-first approach; Borderline resectable pancreatic cancer; Meso-pancreatoduodenum; Mesopancreatic plane surgery; Pancreaticoduodenectomy

Mesh:

Year:  2016        PMID: 26995116     DOI: 10.1016/j.ejso.2016.02.241

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

1.  Systematic review of the mesopancreas: concept and clinical implications.

Authors:  J M Ramia; R De-la-Plaza; A Manuel-Vazquez; A Lopez-Marcano; R Morales
Journal:  Clin Transl Oncol       Date:  2018-04-19       Impact factor: 3.405

Review 2.  What do surgeons need to know about the mesopancreas.

Authors:  Eduardo de Souza M Fernandes; Oliver Strobel; Camila Girão; Jose Maria A Moraes-Junior; Orlando Jorge M Torres
Journal:  Langenbecks Arch Surg       Date:  2021-06-12       Impact factor: 3.445

3.  Technical details of a left-side approach to the superior mesenteric artery during pancreaticoduodenectomy.

Authors:  Katsunori Sakamoto; Kohei Ogawa; Akihiro Takai; Kei Tamura; Mikiya Shine; Takashi Matsui; Yusuke Nishi; Takeshi Utsunomiya; Hitoshi Inoue; Seiji Matsuda; Yasutsugu Takada
Journal:  Surg Today       Date:  2021-02-27       Impact factor: 2.549

4.  Anatomical Study of the Duodenojejunal Uncinate Process Vein: A Key Landmark for Mesopancreatoduodenal Resection During Pancreaticoduodenectomy.

Authors:  Masahiko Honjo; Taiji Tohyama; Kohei Ogawa; Kei Tamura; Katsunori Sakamoto; Akihiro Takai; Jota Watanabe; Hiromi Ohtani; Yasutsugu Takada
Journal:  Ann Gastroenterol Surg       Date:  2021-10-12

Review 5.  Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy.

Authors:  Danko Mikulic; Anna Mrzljak
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

6.  Clinical evaluation of modified invaginated pancreaticojejunostomy for pancreaticoduodenectomy.

Authors:  Dong Wang; Xiao Liu; Hongwei Wu; Kun Liu; Xiaona Zhou; Jun Liu; Wei Guo; Zhongtao Zhang
Journal:  World J Surg Oncol       Date:  2020-04-15       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.